Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial
暂无分享,去创建一个
F. Glorieux | H. Cheong | E. Sochett | M. Whyte | J. Simmons | A. Biggin | N. Namba | K. Muroya | O. Nilsson | W. Högler | R. Padidela | C. Munns | L. Ward | A. Portale | Farzana Perwad | G. Gottesman | P. Pitukcheewanont | E. Imel | Javier San Martin | M. Mao | A. Skrinar | Hiroyuki Tanaka | Chao‐Yin Chen
[1] J. S. San Martin,et al. Rickets severity predicts clinical outcomes in children with X-linked hypophosphatemia: Utility of the radiographic Rickets Severity Score. , 2019, Bone.
[2] J. S. San Martin,et al. Efficacy and safety of burosumab in children aged 1-4 years with X-linked hypophosphataemia: a multicentre, open-label, phase 2 trial. , 2019, The lancet. Diabetes & endocrinology.
[3] J. S. San Martin,et al. Burosumab Therapy in Children with X‐Linked Hypophosphatemia , 2018, The New England journal of medicine.
[4] W. Mcalister,et al. Validation of a Novel Scoring System for Changes in Skeletal Manifestations of Hypophosphatasia in Newborns, Infants, and Children: The Radiographic Global Impression of Change Scale , 2018, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[5] Yvette N. Lamb. Burosumab: First Global Approval , 2018, Drugs.
[6] K. Briot,et al. Phosphate and Vitamin D Prevent Periodontitis in X-Linked Hypophosphatemia , 2017, Journal of dental research.
[7] Raghbir Kaur,et al. Conventional Therapy in Adults With X-Linked Hypophosphatemia: Effects on Enthesopathy and Dental Disease. , 2015, The Journal of clinical endocrinology and metabolism.
[8] M. McKee,et al. Abnormal osteopontin and matrix extracellular phosphoglycoprotein localization, and odontoblast differentiation, in X-linked hypophosphatemic teeth , 2014, Connective tissue research.
[9] P. Wicart,et al. Therapeutic management of hypophosphatemic rickets from infancy to adulthood , 2014, Endocrine connections.
[10] I. Holm,et al. A clinician's guide to X‐linked hypophosphatemia , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[11] D. Haffner,et al. Age-related stature and linear body segments in children with X-linked hypophosphatemic rickets , 2011, Pediatric Nephrology.
[12] M. Goldberg,et al. Dentin structure in familial hypophosphatemic rickets: benefits of vitamin D and phosphate treatment. , 2007, Oral diseases.
[13] A. Loeckinger,et al. Six-minute walk test in children and adolescents. , 2007, The Journal of pediatrics.
[14] M. Goldberg,et al. Dentin Alteration of Deciduous Teeth in Human Hypophosphatemic Rickets , 2006, Calcified Tissue International.
[15] N. Bishop,et al. Rickets , 1906, The Lancet.
[16] Shumei S. Guo,et al. 2000 CDC Growth Charts for the United States: methods and development. , 2002, Vital and health statistics. Series 11, Data from the National Health Survey.
[17] Shumei S. Guo,et al. CDC GROWTH CHARTS FOR THE UNITED STATES: METHODS AND DEVELOPMENT 2000 , 2002 .
[18] B. Manaster,et al. Radiographic scoring method for the assessment of the severity of nutritional rickets. , 2000, Journal of tropical pediatrics.
[19] J. Simpson,et al. Effects of therapy in X-linked hypophosphatemic rickets. , 1991, The New England journal of medicine.
[20] G. Lockitch,et al. Age- and sex-specific pediatric reference intervals for biochemistry analytes as measured with the Ektachem-700 analyzer. , 1988, Clinical chemistry.
[21] J. Tanner,et al. Clinical longitudinal standards for height and height velocity for North American children. , 1985, The Journal of pediatrics.
[22] F. Glorieux,et al. X-linked hypophosphatemia: effect of calcitriol on renal handling of phosphate, serum phosphate, and bone mineralization. , 1981, The Journal of clinical endocrinology and metabolism.
[23] F. Glorieux,et al. Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin D-resistant rickets. , 1980, The New England journal of medicine.
[24] F. Glorieux,et al. Use of phosphate and vitamin D to prevent dwarfism and rickets in X-linked hypophosphatemia. , 1972, The New England journal of medicine.
[25] F. N. Silverman,et al. USE OF PHOSPHATE SALTS AS AN ADJUNCT TO VITAMIN D IN THE TREATMENT OF HYPOPHOSPHATEMIC VITAMIN D REFRACTORY RICKETS. , 1964, The Journal of pediatrics.